I know that this title may seem misleading given my positive stance on GLP-1s. However, it highlights a significant issue with periodicals and their tendency to use clickbait titles. Unfortunately, you often only discover the author's true message after reading through half the article. This can lead to misunderstandings about the importance of these groundbreaking medications. Titles like these can also fuel rumors that patients should stop using these medications when they

Andrew Kowalski, MD, FASN There is a particular cruelty in poisons that announce themselves slowly. Like a slow, known, attack that you may see coming on, but cannot do anything about…a cancer of sorts. Unlike the dramatic presentation of acute toxicity; the seizure, the organ failure, the unmistakable collapse. Chronic low-level contamination operates in a register barely perceptible to the patient and often invisible to the clinician. Heavy metals and microplastics are two

A summary and commentary on: Čižman B, Butler EL, Stavas J, et al. A Randomized Clinical Trial of Kidney Autologous Cell Therapy in Diabetic Kidney Disease. Clin J Am Soc Nephrol. Published January 2, 2026. doi:10.2215/CJN.0000000969 So if you have not heard, there has been some excitement in the world of kidney disease lately! An article came out in January 2026 discussing a possible and promising use of stem cell therapy to address diabetic kidney disease. Why Are We Excite